Taiwan announced its first confirmed case of the Mu variant of COVID-19, a Taiwanese woman who had received two Pfizer vaccine doses in the U.S. Taiwan’s first case of the Mu variant was originally diagnosed with COVID-19 on August 13th. The infected person is a Taiwanese woman in her 60s who had returned from the U.S. in early August.
She had received the first dose of the Pfizer vaccine in the U.S. on July 5th and the second on July 26th. When she returned to Taiwan on August 3rd, she did not report any symptoms, but a test administered at the airport revealed that she was positive for COVID, with a Ct value of 29.
Thirteen new adverse events, including four serious ones, have been reported among the over 9,200 people who had received their first dose of the AstraZeneca vaccine in Taiwan, as of Friday, according to the Central Epidemic Command Center, CNA reports.
Taiwan has recorded a total of 27 adverse events, including the newly reported 13 cases, since the roll-out of the vaccination began on Monday, CECC official Lo Yi-chun said Saturday.
This was the first time the CECC has reported serious adverse events since a nurse in New Taipei became the first person to experience a severe reaction after receiving the vaccine on Wednesday.